CompletedNot Applicable

Neutrophil-to Lymphocyte and Monocyte-to-Lymphocyte Ratios in Exudative Pleural Effusion

Egypt60 participantsStarted 2025-05-11

Plain-language summary

Exudative pleural effusion (EPE) presents a diagnostic challenge, requiring accurate biomarkers to predict outcomes and guide treatment. The neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) in pleural fluid are emerging as potential prognostic markers. We aimed to assess the diagnostic and prognostic utility of pleural fluid NLR and MLR in EPE.

Who can participate

Age range18 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients aged 18-80 years with an EPE diagnosis confirmed by thoracentesis. Exclusion Criteria: * Exclusion criteria included patients with a history of recent surgery, corticosteroid use, or those with mixed effusion types.

What they're measuring

MLR and NLR measuring in pleural fluid

Timeframe: 1 month

Trial details

NCT IDNCT07003204

SponsorAlexandria University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-05-25

View on ClinicalTrials.gov More Effusion trials